RE: Reagent sales31 Jul 2025 15:26
Agreed, this all looks very promising and no doubt why Directors recently chipped in £70k. With an existing
Revenue stream from MicroTox / CLM’s being added to by SRB Kits & the possibility of PFAS Test equipment meeting requirements, plus Pathogen Dectection, the product range is expanding nicely. Don’t normally touch penny stocks but with a fair wind suspect this won’t be in that category in a few years time !